Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mu... Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5.67 | -12.3260869565 | 46 | 46 | 34.1301 | 28950 | 39.32157345 | CS |
| 4 | 10.33 | 34.4333333333 | 30 | 47.8252 | 27.05 | 32169 | 34.58429928 | CS |
| 12 | 19.32 | 91.9562113279 | 21.01 | 54.3 | 21 | 51720 | 37.54910349 | CS |
| 26 | 33.19 | 464.845938375 | 7.14 | 54.3 | 4.5 | 298543 | 26.79527263 | CS |
| 52 | 36.825 | 1050.64194009 | 3.505 | 54.3 | 1.719 | 396916 | 12.43981764 | CS |
| 156 | 27.83 | 222.64 | 12.5 | 54.3 | 1.3695 | 720816 | 6.15368722 | CS |
| 260 | 6.08 | 17.7518248175 | 34.25 | 85.05 | 1.3695 | 463607 | 8.32482328 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
